Choosing between shotgun metagenomics and metatranscriptomics comes down to a single question: does your study need to know what a microbial community can do, or what it is doing right now? Shotgun metagenomics sequences all the DNA in a sample and yields a "static map" of genetic potential — species composition, gene content, and predicted metabolic pathways. Metatranscriptomics sequences the RNA, primarily mRNA, and yields a "dynamic image" of real-time gene expression and metabolic activity. The two are complementary lenses, not competing substitutes.
Understanding the Microbiome: Beyond 16S rRNA
For years, microbiome research leaned on 16S rRNA gene sequencing, a method that identifies and compares the bacteria present in a sample by targeting a single phylogenetic marker. It answers "who is there" — but not what those organisms are equipped to do. That limitation pushed the field toward methods that sample the community's full genetic and functional content.
Next-generation sequencing now offers two broader experimental approaches for the human microbiome, as described in Illumina's technical overview of microbiome analysis: shotgun metagenomic sequencing, which enables comprehensive sampling of all genes in all organisms in a complex microbial sample, and microbial metatranscriptomics, the analysis of all RNAs encoded by a group of microorganisms in a complex sample. The second approach lets researchers quantify gene expression changes, study host-pathogen immune interactions, and track disease progression.
The distinction matters because composition alone rarely explains health associations. A community's membership tells you little about which metabolic pathways are actually running in a diseased gut or a responding host. Function — both potential and realized — is where the newer methods earn their place.





